Methylnaltrexone

BNF:
1.6.6
Status:
Grey - after consultant/specialist recommendation
Decision Date:
October 2011
 

Comments

GREY after consultant/specialist recommendation:1,5 Reclassified from red - allows palliative care patients timely access to drug

NICE TA277: for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care - terminated appraisal (April 2013)

Grey Drug Classifications

  • 1: Lack of data on effectiveness compared with standard therapy
  • 5: Less cost-effective than current standard therapy

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app